The importance of serum biglycan levels as a fibrosis marker in patients with chronic hepatitis B
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Laboratory Analysis"
DOI: 10.1002/jcla.22109
Abstract: Liver biopsy is recommended in the majority of patients with chronic viral hepatitis for fibrosis evaluation. Because of the potential risks of liver biopsy, many studies related to non‐invasive biomarkers of hepatic fibrosis have been… read more here.
Keywords: serum biglycan; fibrosis; hepatitis; fibrosis marker ... See more keywords